234 related articles for article (PubMed ID: 37344896)
1. Enhancing global health diplomacy for non-communicable diseases: application of the global health network framework.
Afshari M; Teymourlouy AA; Maleki M; Asadi-Lari M
Global Health; 2023 Jun; 19(1):41. PubMed ID: 37344896
[TBL] [Abstract][Full Text] [Related]
2. Global Health diplomacy for noncommunicable diseases prevention and control: a systematic review.
Afshari M; Ahmadi Teymourlouy A; Asadi-Lari M; Maleki M
Global Health; 2020 May; 16(1):41. PubMed ID: 32375804
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities for Iranian global health diplomacy: lessons learned from action for prevention and control of noncommunicable diseases.
Asadi-Lari M; Ahmadi Teymourlouy A; Maleki M; Eslambolchi L; Afshari M
Health Res Policy Syst; 2021 Dec; 19(1):152. PubMed ID: 34952614
[TBL] [Abstract][Full Text] [Related]
4. Opportunities and challenges of global health diplomacy for prevention and control of noncommunicable diseases: a systematic review.
Asadi-Lari M; Ahmadi Teymourlouy A; Maleki M; Afshari M
BMC Health Serv Res; 2021 Nov; 21(1):1193. PubMed ID: 34736461
[TBL] [Abstract][Full Text] [Related]
5. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
[TBL] [Abstract][Full Text] [Related]
6. Global health diplomacy in Mexico: insights from key actors in the field.
Guerra G; Orozco E; Jiménez P; Ruckert A; Labonté R; Snyder NS
Global Health; 2021 Dec; 17(1):137. PubMed ID: 34857013
[TBL] [Abstract][Full Text] [Related]
7. The process of prioritization of non-communicable diseases in the global health policy arena.
Heller O; Somerville C; Suggs LS; Lachat S; Piper J; Aya Pastrana N; Correia JC; Miranda JJ; Beran D
Health Policy Plan; 2019 Jun; 34(5):370-383. PubMed ID: 31199439
[TBL] [Abstract][Full Text] [Related]
8. Curbing the Rise of Noncommunicable Diseases in Uganda: Perspectives of Policy Actors.
Meghani A; Ssemugabo C; Pariyo G; Hyder AA; Rutebemberwa E; Gibson DG
Glob Health Sci Pract; 2021 Mar; 9(1):149-159. PubMed ID: 33795366
[TBL] [Abstract][Full Text] [Related]
9. Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.
Bakhtiari A; Takian A; Majdzadeh R; Haghdoost AA
BMC Public Health; 2020 Mar; 20(1):333. PubMed ID: 32171267
[TBL] [Abstract][Full Text] [Related]
10. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
Buse K; Tanaka S; Hawkes S
Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
[TBL] [Abstract][Full Text] [Related]
11. Identifying key factors for successful formulation and implementation of healthcare policies on non-communicable diseases: a multinational analysis.
Babaita AO; Jahan Y; Nakamura R; Moriyama M
Front Public Health; 2024; 12():1292176. PubMed ID: 38389939
[TBL] [Abstract][Full Text] [Related]
12. Big food and the World Health Organization: a qualitative study of industry attempts to influence global-level non-communicable disease policy.
Lauber K; Rutter H; Gilmore AB
BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34117011
[TBL] [Abstract][Full Text] [Related]
13. Intersectoral collaboration in the management of non-communicable disease's risk factors in Iran: stakeholders and social network analysis.
Bakhtiari A; Takian A; Majdzadeh R; Ostovar A; Afkar M; Rostamigooran N
BMC Public Health; 2022 Sep; 22(1):1669. PubMed ID: 36056315
[TBL] [Abstract][Full Text] [Related]
14. Policy analysis of nutrition stewardship for prevention and control of Non-communicable diseases in Iran.
Amerzadeh M; Takian A; Pouraram H; Sari AA; Ostovar A
BMC Health Serv Res; 2023 Jan; 23(1):79. PubMed ID: 36694184
[TBL] [Abstract][Full Text] [Related]
15. Responding to non-communicable diseases in Zambia: a policy analysis.
Mukanu MM; Zulu JM; Mweemba C; Mutale W
Health Res Policy Syst; 2017 Apr; 15(1):34. PubMed ID: 28438177
[TBL] [Abstract][Full Text] [Related]
16. Port of Spain Summit Declaration as a successful outcome of global health diplomacy in the Caribbean region: a systematic review.
Chattu VK; Knight AW
Health Promot Perspect; 2019; 9(3):174-180. PubMed ID: 31508337
[No Abstract] [Full Text] [Related]
17. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB
Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604
[TBL] [Abstract][Full Text] [Related]
18. Framing global discourses on non-communicable diseases: a scoping review.
Tan MMJ; Han E; Shrestha P; Wu S; Shiraz F; Koh GC; McKee M; Legido-Quigley H
BMC Health Serv Res; 2021 Jan; 21(1):20. PubMed ID: 33407447
[TBL] [Abstract][Full Text] [Related]
19. Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases.
Suzuki M; Webb D; Small R
Int J Health Policy Manag; 2022 Jul; 11(7):1078-1089. PubMed ID: 33619925
[TBL] [Abstract][Full Text] [Related]
20. Global health diplomacy, 'smart power', and the new world order.
Kevany S
Glob Public Health; 2014; 9(7):787-807. PubMed ID: 24953683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
